Allergan Says Asacol Buyers' Generic-Delay Suit Defective
Allergan is seeking to end a suit brought by buyers of its ulcerative colitis drug who allege a company subsidiary sought to delay generic competition, telling a Massachusetts federal court the...To view the full article, register now.
Already a subscriber? Click here to view full article